Featured Events

Presidential Symposium

Wednesday, November 6, 5:00 pm – 6:30pm MT

This special session organized by the ASHG President addresses a topic the President finds particularly relevant, pressing, or novel in the human genetics and genomics research community.

Moderator

Bruce D. Gelb, MD, Dean for Child Health Research, Gogel Family Chair and Director of The Mindich Child Health and Development Institute, Director of the Center for Molecular Cardiology, and Professor of Pediatrics and Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai
Bruce D. Gelb, MD
Dean for Child Health Research, Gogel Family Chair and Director of The Mindich Child Health and Development Institute, Director of the Center for Molecular Cardiology, and Professor of Pediatrics and Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai

Speakers

Gregory Radick, PhD, Professor, University of Leeds
Gregory Radick, PhD,
Professor, University of Leeds
Athena Starlard-Davenport, PhD, Associate Professor, University of Tennessee Health Science Center
Athena Starlard-Davenport, PhD,
Associate Professor, University of Tennessee Health Science Center
Stanislav Y. Shvartsman, PhD, Professor, Princeton University
Stanislav Y. Shvartsman, PhD,
Professor, Princeton University

Distinguished Speakers Symposium

Saturday, November 9, 11:00 am – 12:30pm MT

This special session, organized by the Program Committee, closes the Annual Meeting by featuring leaders in the human genetics and genomics community in a series of exciting talks related to the future of human genetics followed by Q&A.

The Promise and Payoff of Human Genetics and Genomics: Paths from Bench to Bedside

A major goal of human genetics and genomics research is to understand, treat, and correct genetic diseases and alleviate patient suffering. However, moving discoveries from the bench to the bedside can be both daunting and lengthy. The 2024 Distinguished Speakers Symposium will feature leaders who have made important basic science discoveries and navigated the journey from discovery to drug development, clinical trials, and implementation of new therapies. Their work has given hope to patients and framed the ethics, policy, and communication around ground-breaking genetics and genomics research.

Moderators:

Gillian Hooker, PhD, ScM, Chief Scientific Officer, Concert and Adjunct Associate Professor, Vanderbilt University Medical Center
Gillian Hooker, PhD, ScM,
Chief Scientific Officer, Concert and Adjunct Associate Professor, Vanderbilt University Medical Center
Lizeth Tamayo, PhD, Scientist, Tempus AI
Lizeth Tamayo, PhD,
Scientist, Tempus AI

Speakers

Crystal Y. Lumpkins
Crystal Y. Lumpkins, PhD, MA, FSBM,
Associate Professor, Huntsman Cancer Institute
David Goldstein, PhD, CEO
David Goldstein, PhD,
CEO, Actio Biosciences, Inc.
Heather Hampel, MS, CGC
Heather Hampel, MS, CGC,
Associate Director, Division of Clinical Cancer Genomics, City of Hope National Medical Center
David Altshuler, MD, PhD, EVP
David Altshuler, MD, PhD,
EVP, Global Research and Chief Scientific Officer, Vertex Pharmaceuticals, Inc.

For more information on our session participants, read their biographies.

Questions?

Contact ASHG

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy